Trending...
- Boston Industrial Solutions Launches Natron® 348 UV Inkjet Ink for Epson S3200 Print Heads
- Philadelphia Scientist Roohid Parast Applies Evidence-Based Research to Elite Personal Fitness
- Eichelberger Performing Arts Center Announces Fall 2026 Performance Lineup
PHILADELPHIA, May 3, 2021 /PRNewswire/ -- Six lawsuits have been filed in federal courts across three states - Pennsylvania, California and Illinois - alleging a link between Paraquat, the widely-banned herbicide, and incurable Parkinson's disease. The lawsuits include the first cases filed in the Pennsylvania courts. The Complaints were jointly filed by a team of leading national toxic torts attorneys from DiCello Levitt Gutzler ("DLG"), Saltz Mongeluzzi & Bendesky, P.C. ("SMB") and Searcy Denney. Parkinson's Awareness Month events concluded Friday, the same day as the filings.
Mark DiCello, of Midwest-based DLG and frequent lead plaintiff's counsel in pivotal multidistrict litigation (MDL) in a wide range of mass tort and product liability cases, said the simultaneous filings signal a significant milestone in the rapidly increasing Paraquat-Parkinson's disease litigation as "three of the nation's leading catastrophic injury and mass tort firms join forces in the fight against the manufacturers and marketers of Paraquat who have long known they were peddling this poison. They must be held accountable through the American justice system." He added, "Our firms have collectively been retained by several hundred clients to date; we'll be seeking a leadership seat at the litigation table, and strongly believe the science is conclusively on the side of the plaintiffs."
More on The PennZone
Jeffrey P. Goodman, a partner at SMB added "These filings are only the tip of the iceberg with what is expected to be the next major mass tort. The manufacturers of paraquat knew for decades that their product was linked to Parkinson's disease yet chose to hide this information from regulators and the public." The defendants named in all six complaints are: Syngenta Crop Protection, LLC, a Delaware corporation, Swiss-headquartered Syngenta AG, and Chevron USA, Inc., a Pennsylvania-registered corporation.
Lawrence R. Cohan, also an SMB partner, heads the firm's mass torts practice and commented "We are honored to file the first Pennsylvania-Paraquat cases to obtain justice for our current and future clients who unknowingly were exposed to this hazardous agricultural chemical – banned in more than 32 countries, among them China and the European Union nations," said Mr. Cohan, who has successfully litigated against global producers of toxic products over his career. Joining Mr. Goodman and Mr. Cohan on SMB's legal team are firm President Robert J. Mongeluzzi and attorneys Josh Cohan and Samuel B. Dordick.
Co-counsel Cal Warriner, of West Palm, Florida-based Searcy Denney, has also served in a plaintiff's leadership role in numerous other mass tort cases, and did not hesitate to join the group in the fight for justice. He said, "We are honored to be a part of this distinguished team of nationally recognized trial lawyers. Our clients need and deserve a strong voice to underscore the injustice they've been dealt. To be stricken with such a horrible disease from an innocent workplace exposure is very sad. We are ready to fight for them." Co-counsel on the California cases is Pete Kaufman with Panish, Shea & Boyle LLP.
More on The PennZone
NOTE: Legal team members will be available for interviews on behalf of the plaintiffs. More information about Parkinson's, including activities during Parkinson's Awareness Month can be found from numerous sources including the Parkinson's Foundation and Michael J. Fox Foundation / Unified Parkinson's Council. The 2011 National Institutes of Health report on the Paraquat-Parkinson link is at NIH 2011 Study. The six U.S. District Court lawsuit filing numbers are 1) Eastern District of Pennsylvania, No. 2:21-cv-01996-JMY; 2) E.D. Pa. No. 2:21-02013; 3) E.D. Pa. No. 2:1:02016 4) Southern District of Illinois, No. 3:21-cv-00439; 5) Northern District of California, No. 3:21-cv-03233; 6) N.D. Cal., No. 3:21-cv-03229.
SOURCE Saltz Mongeluzzi
Mark DiCello, of Midwest-based DLG and frequent lead plaintiff's counsel in pivotal multidistrict litigation (MDL) in a wide range of mass tort and product liability cases, said the simultaneous filings signal a significant milestone in the rapidly increasing Paraquat-Parkinson's disease litigation as "three of the nation's leading catastrophic injury and mass tort firms join forces in the fight against the manufacturers and marketers of Paraquat who have long known they were peddling this poison. They must be held accountable through the American justice system." He added, "Our firms have collectively been retained by several hundred clients to date; we'll be seeking a leadership seat at the litigation table, and strongly believe the science is conclusively on the side of the plaintiffs."
More on The PennZone
- Longevityresearch.ca Unveils a Unique Bayesian Causal Atlas; Saves up to 7.9 life years/patient
- Grane Rx, a National Pharmacy Partner to PACE Programs, Names Scott Sosso President
- K2 Integrity Acquires RiskFront AI to Deliver AI Automation for Financial Crime Compliance and Risk Operations
- HousingWire acquires Keeping Current Matters, putting local market data into the tools agents use to win listings
- KIDZONET & Ocean Telecom Launch UK First eSIM Child Protection — EasySim AI Safe SIM Cards
Jeffrey P. Goodman, a partner at SMB added "These filings are only the tip of the iceberg with what is expected to be the next major mass tort. The manufacturers of paraquat knew for decades that their product was linked to Parkinson's disease yet chose to hide this information from regulators and the public." The defendants named in all six complaints are: Syngenta Crop Protection, LLC, a Delaware corporation, Swiss-headquartered Syngenta AG, and Chevron USA, Inc., a Pennsylvania-registered corporation.
Lawrence R. Cohan, also an SMB partner, heads the firm's mass torts practice and commented "We are honored to file the first Pennsylvania-Paraquat cases to obtain justice for our current and future clients who unknowingly were exposed to this hazardous agricultural chemical – banned in more than 32 countries, among them China and the European Union nations," said Mr. Cohan, who has successfully litigated against global producers of toxic products over his career. Joining Mr. Goodman and Mr. Cohan on SMB's legal team are firm President Robert J. Mongeluzzi and attorneys Josh Cohan and Samuel B. Dordick.
Co-counsel Cal Warriner, of West Palm, Florida-based Searcy Denney, has also served in a plaintiff's leadership role in numerous other mass tort cases, and did not hesitate to join the group in the fight for justice. He said, "We are honored to be a part of this distinguished team of nationally recognized trial lawyers. Our clients need and deserve a strong voice to underscore the injustice they've been dealt. To be stricken with such a horrible disease from an innocent workplace exposure is very sad. We are ready to fight for them." Co-counsel on the California cases is Pete Kaufman with Panish, Shea & Boyle LLP.
More on The PennZone
- School Dental Screening Programs Conducted in Dubai
- British Brand Daniel Mason™ Expands Premium Braided Leather Belt Collection Internationally
- Looking for expert pool tiling in Gold Coast? Call Avid Tiling
- Hosted Network Powers National Growth with netElastic vBNG, CGNAT and netVision
- Individual Entrepreneur of Annville, PA, Acquires Mosquito Joe of Lancaster, PA
NOTE: Legal team members will be available for interviews on behalf of the plaintiffs. More information about Parkinson's, including activities during Parkinson's Awareness Month can be found from numerous sources including the Parkinson's Foundation and Michael J. Fox Foundation / Unified Parkinson's Council. The 2011 National Institutes of Health report on the Paraquat-Parkinson link is at NIH 2011 Study. The six U.S. District Court lawsuit filing numbers are 1) Eastern District of Pennsylvania, No. 2:21-cv-01996-JMY; 2) E.D. Pa. No. 2:21-02013; 3) E.D. Pa. No. 2:1:02016 4) Southern District of Illinois, No. 3:21-cv-00439; 5) Northern District of California, No. 3:21-cv-03233; 6) N.D. Cal., No. 3:21-cv-03229.
SOURCE Saltz Mongeluzzi
Filed Under: Business
0 Comments
Latest on The PennZone
- Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
- Fourth Annual Free Training Day Mid-Atlantic Returns Sept. 19, 2026
- Las Vegas Headliner Don Barnhart Brings National Touring Comedy Show to Comedy Cabana
- Nevada Boxing Hall of Fame Announces 14th Annual Induction Gala Weekend Honoring Classes of 2025 and 2026
- Brosix Celebrates 20 Years of Private Team Messaging for Small and Mid-Sized Businesses
- Top 15 Mosquito-Infested Cities in Louisiana and East Texas Ranked for 2026 Mosquito Season
- Colonial Nissan Enhances Ownership Experience with Hall of Fame Package
- From Broken to Soaring Week 40
- Costa Oil Takes the Spotlight as Primary Sponsor at Pocono, Celebrates Team with Employee Appreciation Day Costa Oil to back the
- MoMojo Records announces new album from Mitch Woods
- Finnish Political Satire Film Generates 10,000+ Cross-Platform Interactions Following Gandalf Parody Video Across TikTok, YouTube and Telegram
- Baikal Engineers Published in ASHRAE Journal on Site-Assembled Custom AHUs
- AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
- 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
- Eichelberger Performing Arts Center Announces Fall 2026 Performance Lineup
- netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
- IWS Press Expands Best-Selling Classic Wealth Library with Seventh Book
- Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent
- Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
- Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029